Tim Windle

Prostate Cancer UK

Tim Windle is the Policy Manager at Prostate Cancer UK where he has led the charity’s work on access to treatments for the past two and half years. He has been a member of NHSE England’s Chemotherapy Clinical Reference Group which oversees the commissioning of cancer medicines in the NHS. He is also part of a number of charity groups including the Charity Medicines Access Coalition and Access to Cancer Medicines Coalition. He previously worked at The Association of the British Pharmaceutical Industry, the trade body for branded pharmaceutical companies in the UK.

dont miss

Why research isn’t enough for patient access: the technology appraisal process

This session will explore what happens after research publishes and a medicine is licensed. It will seek to highlight some of the challenges and difficulties which mean it can be years before patients are able to access treatments outside private care. It will focus on a particular case study in England and consider what this might mean for translating the future research pipeline into practice.


  • Dr Penny Kechagioglou: Speaking at the Oncology Convention

    Dr Penny Kechagioglou
    GenesisCare UK

    Breast cancer Service of the Future: a service transformation

  • Nicky Robinson: Speaking at the Oncology Convention

    Nicky Robinson
    Penny Brohn UK

    Food as Medicine: Diet and Nutrition in Cancer Care

  • Dr Shanmugasundaram Ramkumar: Speaking at the Oncology Convention

    Dr Shanmugasundaram Ramkumar
    University Hospital Southampton NHS Foundation Trust

    Radiotherapy developments in management of recurrent rectal cancers

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view

  • Dr. Konstantinos Vougas: Speaking at the Oncology Convention

    Dr. Konstantinos Vougas
    DeepMed IO Ltd

    AI in decision support of diagnostic and personalised medicine applications.